Arantes, Ricardo Vinicius Nunes <br/><br/>
Meloxicam temporally inhibits the expression of vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 during alveolar bone repair in rats.  [electronic resource] 

 -  Journal of periodontology  Jan 2015 
 - 162-72 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1943-3670 
<br/><br/><label>Standard No.: </label>10.1902/jop.2014.140259  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alveolar Process--drug effects<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Bone Density--drug effects<br/>Bone Remodeling--drug effects<br/>Cyclooxygenase 2 Inhibitors--pharmacology<br/>Down-Regulation<br/>Isoenzymes--antagonists & inhibitors<br/>Male<br/>Maxilla--drug effects<br/>Meloxicam<br/>Osteoclasts--pathology<br/>Osteogenesis--drug effects<br/>Rats<br/>Rats, Wistar<br/>Signal Transduction--drug effects<br/>Thiazines--pharmacology<br/>Thiazoles--pharmacology<br/>Time Factors<br/>Tooth Socket--drug effects<br/>Vascular Endothelial Growth Factor A--drug effects<br/>Vascular Endothelial Growth Factor Receptor-1--drug effects<br/>Vascular Endothelial Growth Factor Receptor-2--drug effects